Abstract

Abstract Breast cancer (BC) is the leading cause of death of women between 40 and 55 years of age and is the second overall cause of death of women. Fortunately, the mortality rate from BC has decreased in recent years due to an increased emphasis on early detection and more effective treatments. Despite early detection and conventional methods of treatment, about 7% of women diagnosed with BC still die every year. Therefore, novel therapeutic agents are needed to improve the clinical outcome of this disease. The development of new drugs from natural products is considered important. Previous studies from our laboratory show that a novel natural product, extracts of Vernonia amygdalina (VA) leaf exerts DNA-damaging anticancer activities against BC. Therefore, the central goal of this research was to determine the therapeutic mechanisms of VA leaf extracts in breast cancer cells. To achieve this goal, cell viability, live and death cells were determined by the means of the MTT assay, trypan blue test, and propidium iodine assay, respectively. Cell apoptosis was measured by flow cytometry analysis of phosphatidylserine externalization (Annexin V assay) and caspase 3 activity, and by DNA laddering assay. Data obtained from the MTT assay indicated that VA significantly reduced the viability of MCF-7 cells a dose-dependent response. On one hand, the Trypan blue dye exclusion test demonstrated the integrity of the membrane of untreated cells in culture. On the other hand, the trypan blue dye exclusion test demonstrated a loss of viability in VA-treated cells due to membrane damage. The result of the propidium iodine demonstrated a significant (p<0.05) increase of necrotic cell death in VA-treated cells, indicative of membrane rupture by VA. Flow cytometry data showed a strong dose-response relationship between VA exposure and Annexin-V positive MCF-7 cells. These results were confirmed by data of DNA laddering assay showing a clear evidence of nucleosomal DNA fragmentation in VA-treated cells. A statistically significant was recorded with regard to caspase 3 activity in MCF-7 cells. Taken together, our research demonstrated that VA represents an apoptosis-inducing agent and its apoptotic mechanisms involve phosphatidylserine externalization, activation of p53 tumor suppressor gene and caspase-3, and nucleosomal DNA fragmentation. Citation Format: Clement G. Yedjou, Paul Tchounwou. Mechanisms of Vernonia amygdalina-induced apoptosis of human breast adenocarcinoma (MCF-7) cells. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1237. doi:10.1158/1538-7445.AM2014-1237

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.